Sang-Moo Kang

Sang-Moo Kang is a Distinguished University Professor at Georgia State University's Institute for Biomedical Sciences. His research focuses on universal vaccine development against influenza, RSV, and SARS-CoV-2, emphasizing understanding immune mechanisms and aging-related immunity.

• Education: Ph.D. in Microbiology and Immunology, University of Alabama at Birmingham (1998)

Dr. Kang's work addresses challenges in cross-protective immunity through technologies like mRNA vaccines, virus-like particles, and adjuvant optimization. His team investigates correlates of protection, vaccine-induced inflammation, and aging effects on immune responses.

Recent publications highlight universal influenza vaccine strategies combining HA stalk, NA, and M2e epitopes, alongside advancements in mRNA-LNP platforms and adjuvant systems. His research has significant implications for pandemic preparedness.

• Scientific Awards: Distinguished University Professor

Dr. Kang's lab employs systems biology and preclinical models to evaluate vaccine efficacy in young and aged populations. His work bridges fundamental immunology with translational vaccine development.